Drug-eluting bead therapy in primary and metastatic disease of the liver

HPB

Volumn 11, Issue 7, 2009, Pages 541-550

  Carter, Stewart ^a   Martin II, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Chemoembolization; Doxorubicin; Drug eluting bead; Irinotecan; Liver directed therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; IRINOTECAN; MITOMYCIN C; NANOBEAD;

ABDOMINAL PAIN; BILE DUCT CARCINOMA; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; EMBOLISM; FEVER; GASTRIC ULCER BLEEDING; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; INOPERABLE CANCER; LENGTH OF STAY; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; LUNG EMBOLISM; MORTALITY; NAUSEA AND VOMITING; NEUROENDOCRINE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; REVIEW; SEPSIS; SYSTEMATIC REVIEW;

EID: 73349135338     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00071.x     Document Type: Review

References (29)

1. El Serag HB, Davila JA, Petersen NJ, McGlynn KA. (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139:817-823.
2. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El Serag HB (2004) Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127:1372-1380.
3. Parkin DM, Bray F, Ferlay J, Pisani P. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
4. Bosch FX, Ribes J, Cleries R, Diaz M. (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191-211, v.
5. Srivatanakul P, Sriplung H, Deerasamee S. (2004) Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 5:118-125.
6. Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP. (2008) National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis 5:A74.
7. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96.
8. Martin RCG, Abell T, McMasters KM. (2003) Optimal management of colorectal liver metastases: A decision analysis perspective. Cancer, in press.
9. Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC. (2009) Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 13:486-491.
10. Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW. (2006) Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17:1335-1343.
11. Lewis AL, Gonzalez MV, Lloyd AW, Hall B, Tang Y, Willis SL et al. (2006) bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335-342.
12. Tang Y, Taylor RR, Gonzalez MV, Lewis AL, Stratford PW. (2006) Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. J Control Release 116:e55-e56.
13. Taylor RR, Tang Y, Gonzalez MV, Stratford PW, Lewis AL. (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30:7-14.
14. Lewis AL, Gonzalez MV, Leppard SW, Brown JE, Stratford PW, Phillips GJ et al. (2007) Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med 18:1691-1699.
15. Malagari K. (2008) Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead. Expert Rev Anticancer Ther 8:1643-1650.
16. Poon RT, Tso WK, Pang RW, Ng KK, Woo R, Tai KS et al. (2007) A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5:1100-1108.
17. Aliberti C, Tilli M, Benea G, Fiorentini G. (2006) Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 26:3793-3795.
18. Fiorentini G, Aliberti C, Turrisi G, Del Conte A, Rossi S, Benea G et al. (2007) Intra-arterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo 21:1085-1091.
19. Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M et al. (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474-481.
20. Lencioni R, Crocetti L, Petruzzi P, Vignali C, Bozzi E, Della PC et al. (2008) Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J Hepatol 49:217-222.
21. Aliberti C, Benea G, Tilli M, Fiorentini G. (2008) Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc Intervent Radiol 31:883-888.
22. Kettenbach J, Stadler A, Katzler IV, Schernthaner R, Blum M, Lammer J et al. (2008) Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol 31:468-476.
23. de Baere T, Deschamps F, Teriitheau C, Rao P, Conengrapht K, Schlumberger M et al. (2008) Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumours with doxorubicin-eluting beads: preliminary results. J Vasc Interv Radiol 19:855-861.
24. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al. (2000) New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216.
25. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430.
26. Kalva SP DBAABLZABSWTJdBWAWS. (2008) Chemoembolisation with Doxorubicin-Eluting Microspheres for Inoperable Hepatocellular Cancer: Initial Results. SIR 2008.
27. Reyes DK GJWTGCHKKI. (2007) Intraarterial doxorubicin-eluting microspheres for patients with unresectable hepatocellular carcinoma: a pilot study. CIRSE 2007.
28. Hong K, Khwaja A, Liapi E et al. (2006) New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2563-2567.
29. Malagari K CKVVEEAEKAGAKD. (2007) Drug eluting beads in the treatment of hepatocellular carcinoma: results of two years follow-up. CIRSE 2007.